Magazine

Medicare Advantage, a private insurer alternative to traditional Medicare, is growing in popularity with retiring baby boomers.

Gilead relinquished its orphan drug status for remdesivir shortly after receiving FDA designation for the treatment.

New models for financing and providing rare disease treatment could make for a sustainable system for patients and employers.

Brooke Whitney, Patra sales solution consultant for employee benefits, and Jessica Caudle, Patra director of employee benefits, give their take.

Q&A with Beazley’s Brian Thompson, Head of U.S. Life, Accident & Health, and Matt LaMarche, Head of U.S. Accident & Health Sales and Business Development

Q&A with Tom Richards, Global Lead, Strategy & Business Development, Cigna

While not as hot as 2019, the M&A market is still more active than just four years ago.

Here are the minimum requirements for all companies to be safe in the new normal.

COVID-19 has primed employers to try new approaches.

An important reminder of the power of collaboration.

Prioritizing your employees’ well-being helps improve your company’s well-being.

As businesses consider bringing employees back into the office, there are some basic decisions to weigh.

The global pandemic is no one’s fault. Let’s not prolong the distress by suing each other.

Psychological capital may be the key for success during times of crisis.

Q&A with Pat Sir, President of Broker Consultant Market, Teladoc Health

Stay-at-home orders don't seem so bad anymore.

Planning a vacation now to someplace special for next year will give everyone something to look forward to.